Clinical Trials Directory

Trials / Completed

CompletedNCT00954616

Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly

Inappropriate Medications and Alzheimer Disease: Prevalence and Associated Factors in Elderly Patients Treated With Anticholinesterase and/or Memantine. MIDA Study.

Status
Completed
Phase
Study type
Observational
Enrollment
636 (actual)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

In each of the 7 French areas that should be involved, patients aged 75 years and over from three different sectors will be included: the geriatric consultation unit (60%) and two kinds of nursing homes, private (20%) and state (10%). Outpatients will be included in chronological order; patients in nursing homes will be included at random. The patients and their families will be asked about the treatments received on the day of inclusion. The inclusion period will extend over a year. The investigating practitioners will be asked to fill in a questionnaire reporting the main clinical data, adverse effects occurrence, and information on the treatment given.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2011-07-01
Completion
2012-01-01
First posted
2009-08-07
Last updated
2014-03-20

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00954616. Inclusion in this directory is not an endorsement.

Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly (NCT00954616) · Clinical Trials Directory